Loading clinical trials...
Loading clinical trials...
The aim of this study was to determine whether long-term (≥ 6 months at the target dose) blockade of ETA receptors using sitaxsentan showed functional benefit in subjects with chronic Heart Failure an...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT05064709 · Heart Failure, Heart Failure With Preserved Ejection Fraction, and more
NCT03338374 · Diastolic Heart Failure
NCT04721314 · Pacemaker, Diastolic Dysfunction, and more
NCT01583881 · Diastolic Heart Failure, Hypertension
NCT00585611 · Diastolic Heart Failure
University of Alabama at Birmingham
Birmingham, Alabama
Mobile Heart Specialists, PC
Mobile, Alabama
Preventative and Research Cardiloogy Providence Hospital
Mobile, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions